Clinical Trial Update: Effect of Genetics on Metabolism of Efavirenz [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated how genetic differences affect the metabolism of efavirenz in people treated for HIV. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Sustiva (efavirenz)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Metabolism | Phase 4 | Status: COMPLETED